Literature DB >> 15070925

The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center.

Allan G Need1, Peter D O'Loughlin, Howard A Morris, Michael Horowitz, B E Christopher Nordin.   

Abstract

It has been known for many years that serum PTH rises with age, and it has been suggested that this rise may contribute to bone loss in postmenopausal women. It has been variously attributed to declining renal function, declining calcium absorption efficiency, and declining serum 25-hydroxyvitamin D [25(OH)D] levels. We studied the effects of age, weight, renal function, radiocalcium absorption, serum ionized calcium, and serum 25(OH)D on serum PTH levels in 918 postmenopausal women attending an osteoporosis center. On simple linear regression, serum PTH was a positive function of age (P = 0.003) and weight (P < 0.001) and an inverse function of serum 25(OH)D (P < 0.001) and serum ionized calcium (P = 0.002). On stepwise regression, serum 25(OH)D was the most significant (negative) determinant of serum PTH, followed in decreasing order of significance by serum ionized calcium (negative) and body weight and age (positive). Serum PTH was not related to radiocalcium absorption. The reciprocal relation between serum PTH and serum 25(OH)D could not be explained by the serum concentration of 1,25-dihydroxyvitamin D, which did not change with age. After adjustment for serum ionized calcium, body weight, and age, the rise in serum PTH appeared to start when serum 25(OH)D fell less than 80 nmol/liter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070925     DOI: 10.1210/jc.2003-031539

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Hormonal and dietary influences on true fractional calcium absorption in women: role of obesity.

Authors:  S A Shapses; D Sukumar; S H Schneider; Y Schlussel; R E Brolin; L Taich
Journal:  Osteoporos Int       Date:  2012-01-27       Impact factor: 4.507

Review 2.  There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase.

Authors:  R Vieth; G El-Hajj Fuleihan
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

3.  Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study.

Authors:  Farahnaz Saleh; Rolf Jorde; Johan Sundsfjord; Egil Haug; Yngve Figenschau
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  Threshold value of serum 25-hydroxyvitamin D concentration in relation to elevated serum parathyroid hormone concentrations in elderly Japanese women.

Authors:  Kazutoshi Nakamura; Mitsue Nashimoto; Yasuo Tsuchiya; Toshiko Saito; Tomoko Nishiwaki; Kimiko Ueno; Yoko Okuda; Rieko Oshiki; Masaharu Yamamoto
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women.

Authors:  M-S M Ardawi; M H Qari; A A Rouzi; A A Maimani; R M Raddadi
Journal:  Osteoporos Int       Date:  2010-04-30       Impact factor: 4.507

6.  Defining vitamin D status by secondary hyperparathyroidism in the U.S. population.

Authors:  A A Ginde; P Wolfe; C A Camargo; R S Schwartz
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

7.  High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors.

Authors:  M-S M Ardawi; A M Sibiany; T M Bakhsh; M H Qari; A A Maimani
Journal:  Osteoporos Int       Date:  2011-04-06       Impact factor: 4.507

8.  Optimal vitamin D status and serum parathyroid hormone concentrations in African American women.

Authors:  John F Aloia; Sonia A Talwar; Simcha Pollack; Martin Feuerman; James K Yeh
Journal:  Am J Clin Nutr       Date:  2006-09       Impact factor: 7.045

9.  Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D₃ load in Japanese subjects.

Authors:  Ryo Okazaki; Toshitsugu Sugimoto; Hiroshi Kaji; Yoshio Fujii; Masataka Shiraki; Daisuke Inoue; Itsuro Endo; Toshio Okano; Takako Hirota; Issei Kurahashi; Toshio Matsumoto
Journal:  J Bone Miner Metab       Date:  2010-06-22       Impact factor: 2.626

Review 10.  The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women.

Authors:  B E C Nordin
Journal:  Osteoporos Int       Date:  2009-05-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.